Expert Analysis of Emerging Atopic Dermatitis Therapy Studies

Provided by the Annenberg Center for Health Sciences.

This activity is supported in part by an independent education grant from Pfizer.

Scroll to the Bottom of this Information to Begin this Course

Release date: May 2, 2017

Valid through: May 1, 2018

Specialty: Dermatology/Allergy

Topic: Atopic Dermatitis

Media: Internet

Estimated Time to Complete Activity: 90 minutes

Target Audience

This activity was developed for dermatologists, pediatricians, primary care physicians, allergists, nurse practitioners, nurses, physician assistants and other clinicians who manage patients with atopic dermatitis.

Program Overview

Lawrence F. Eichenfield, MD, and Jonathan I. Silverberg, MD, PhD, MPH, provide their perspectives on the clinical impact of 6 recently published studies involving the management of patients with atopic dermatitis.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the pathogenesis of atopic dermatitis (AD) and the relevance to development of new treatments for the disease
  • Describe the mechanisms of action, efficacy and safety data for emerging nonsteroidal topical therapies and biologic therapies for AD
  • Discuss how new data and recommendations can impact clinical practices to improve patient care

Credit Available

  • ACCME
  • ANCC (up to 1.5 hours)

All other healthcare professionals completing this course will be issued a statement of participation.

Faculty

Lawrence F. Eichenfield, MD

Chief, Pediatric and Adolescent Dermatology
Rady Children’s Hospital-San Diego
Vice Chair, Department of Dermatology and Professor of Dermatology and Pediatrics
University of California, San Diego School of Medicine
San Diego, California

Jonathan I. Silverberg, MD

Director, Northwestern Medicine Multidisciplinary Eczema Center
Director, Contact Dermatitis Clinic
Northwestern Memorial Hospital
Assistant Professor, Departments of Dermatology, Preventive Medicine and Medical Social Sciences
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Physician Continuing Medical Education

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

A maximum of 1.5 contact hours may be earned for successful completion of this activity.

Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1.5 contact hours.

Credit Designation

A maximum of 1.5 contact hours may be earned for successful completion of this activity.

Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1.5 contact hours.

Disclosures of Conflicts of Interest

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:

Lawrence F. Eichenfield, MD

Consultant
Allergan, Anacor/Pfizer, Galderma, Genentech, Eli Lilly, Otsuka/Medimetriks, Ralaxar, Regeneron/Sanofi, TopMD, Valeant

Research Support
Regeneron/Sanofi

Speakers Bureau
Valeant

Advisory Board
Valeant

Jonathan I. Silverberg, MD

Consultant
AbbVie, Anacor/Pfizer, Eli Lilly, Galderma, GlaxoSmithKline, Kiniksa, Menlo, Pfizer, Proctor & Gamble, Realm, Regeneron/Sanofi

Speakers Bureau
Regeneron/Sanofi

The faculty for this activity have disclosed that there will be discussion about the use of products for non-FDA approved indications.

Additional content planners

The following have no significant relationship to disclose:

Eugene A. Cullen, MD (peer reviewer)

Gregory Scott, PharmD, RPh (medical writer)

Sally Schermer, RN, BSN, MBA, CCRN, CPAN, CAPA (lead nurse planner)

Annenberg Center for Health Sciences

John Bayliss, VP, Business Development,spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Instructions for Participation and Credit

There are no fees for participating and receiving credit for this activity. During the accredited period, participants must read the learning objectives and faculty disclosures; study the educational activity; and complete the post-test and the evaluation form. If you pass the post-test and complete the evaluation, your certificate will be available immediately for download in PDF format.

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.

Disclosure of Unlabeled Use

The faculty for this activity have disclosed that there will be discussion about the use of products for non-FDA approved indications

Disclaimer

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.